Tranexamic Acid Tablet, Film Coated
Product Images NDC 63629-8838

3 FDA label images from Bryant Ranch Prepack · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Tranexamic Acid (NDC 63629-8838). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Label (Lbl636298838)

Label (Lbl636298838)
Label for Tranexamic Acid Tablets USP, 650 mg, film coated tablets in a package of 30. The label includes NDC 63629-8838-1, a barcode, and manufacturer information for Teva Pharmaceuticals USA, Inc. It also shows the labeler Bryant Ranch Prepack. Storage instructions and dosage warnings are present, along with the BRP Pharmaceuticals logo and the indication Rx only.*
FDA Label Image

Structural Formula For Tranexamic Acid (Tranexamic Acid Tablets A202093 1)

Structural Formula For Tranexamic Acid (Tranexamic Acid Tablets A202093 1)
Chemical structure of Tranexamic Acid showing its molecular arrangement with labeled functional groups, including an amino group (NH2) and a carboxylic acid group (CO2H). The structure represents a cyclohexane ring with specific stereochemistry.*
FDA Label Image

Figure 1 (The efficacy of Tranexamic acid tablets 3900 mg/day over 3 menstrual cycles and over 6 menstrual cycles was demonstrated versus placebo in the double-blind, placebo-controlled efficacy studies.)

Figure 1 (The efficacy of Tranexamic acid tablets 3900 mg/day over 3 menstrual cycles and over 6 menstrual cycles was demonstrated versus placebo in the double-blind, placebo-controlled efficacy studies.)
Line graph comparing mean menstrual blood loss (mL) over a treatment period among groups treated with Tranexamic Acid Tablets 3900 mg/day and placebo across 3-cycle and 6-cycle studies. The x-axis shows baseline and cycle time points; the y-axis measures blood loss in milliliters.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.